Clinical Trial Update: First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients with Selected Advanced And/or Metastatic Solid Tumours [Phase 1]

View source ↗

Summary

Phase 1 first-in-human study to evaluate safety, tolerability and antineoplastic activity of OATD-02 in patients with selected advanced/metastatic solid tumours…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Renal Cell Carcinoma

Drugs mentioned

• OATD-02 (OATD-02)

Snippet

Sponsor: Molecure S.A. | Conditions: Advanced Ovarian Carcinoma, Advanced Renal Cell Carcinoma | Phase 1 | Status: RECRUITING